You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Chemicals & Materials

Global Glycine-Pharma Grade Market Study 2016-2026, by Segment (0.99, 0.995, … …), by Market (Antacid, Therapeutic Agent for Muscular Dystrophy, … …), by Company (Ajinomoto, Yuki Gosei Kogyo, … …)

Summary

The global Glycine-Pharma Grade market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
0.99
0.995
0.998
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Antacid
Therapeutic Agent for Muscular Dystrophy
Antidote
Others
Company Coverage (Sales data, Main Products & Services etc.):
Ajinomoto
Yuki Gosei Kogyo
Showa Denko KK
GEO Specialty Chemicals
Chattem Chemicals
Paras Intermediates
Evonik
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Table of Content
1 Industry Overview
1.1 Glycine-Pharma Grade Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Glycine-Pharma Grade Market by Type
2.1 By Type
2.1.1 0.99
2.1.2 0.995
2.1.3 0.998
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 Antacid
3.1.2 Therapeutic Agent for Muscular Dystrophy
3.1.3 Antidote
3.1.4 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
5.1 Ajinomoto (Company Profile, Sales Data etc.)
5.2 Yuki Gosei Kogyo (Company Profile, Sales Data etc.)
5.3 Showa Denko KK (Company Profile, Sales Data etc.)
5.4 GEO Specialty Chemicals (Company Profile, Sales Data etc.)
5.5 Chattem Chemicals (Company Profile, Sales Data etc.)
5.6 Paras Intermediates (Company Profile, Sales Data etc.)
5.7 Evonik (Company Profile, Sales Data etc.)
6 Conclusion